Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released May 5, 2016, after the close
10-Q filed May 5, 2016, 35 days after period end · 0001564590-16-017989
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Revenue | $4.00K | $4.00K | $30.00K | $417.00K |
| Net Income | -$49.76M | -$40.38M | -$17.83M | -$6.12M |
| EPS Diluted | -$0.45 |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.40 |
| -$0.19 |
| -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
